• Explore /
  • Poster
  • / Mature results from EV-101: A phase I study of enfortumab vedotin in patients with metastatic urothelial cancer (mUC).

Mature results from EV-101: A phase I study of enfortumab vedotin in patients with metastatic urothelial cancer (mUC).

Abstract Poster

Authors

null

Jonathan E. Rosenberg

Memorial Sloan Kettering Cancer Center, New York, NY

Jonathan E. Rosenberg , Srikala S. Sridhar , Jingsong Zhang , David C. Smith , Joseph D. Ruether , Thomas W. Flaig , Joaquina Celebre Baranda , Joshua Michael Lang , Elizabeth R. Plimack , Randeep S. Sangha , Elisabeth I. Heath , Jaime R. Merchan , David I. Quinn , Sandy Srinivas , Matthew I. Milowsky , Chunzhang Wu , Elaina M Gartner , Amal Melhem-Bertrandt , Daniel Peter Petrylak

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers

Sub Track

Urothelial Carcinoma

Clinical Trial Registration Number

NCT02091999

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 377)

DOI

10.1200/JCO.2019.37.7_suppl.377

Abstract #

377

Poster Bd #

F12

Abstract Disclosures

Similar Posters

First Author: Christopher J. Hoimes

First Author: Daniel Peter Petrylak

First Author: Daniel Peter Petrylak

First Author: Christopher J. Hoimes